Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
World game at war: why some European nations have threatened a World Cup boycott 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
PLEASANTON, Calif., April 11, 2018 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2018 first quarter financial results before the market opens on Wednesday, April 25th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 3261649. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 3261649.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, neurosurgery, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President and Chief Financial Officer
(925) 223-6700
[email protected]
